I am a
Home I AM A Search Login

Papers of the Week

Papers: 31 Aug 2019 - 6 Sep 2019

Pharmacology/Drug Development

2019 Nov 15

Eur J Med Chem


Discovery of dual-acting opioid ligand and TRPV1 antagonists as novel therapeutic agents for pain.


Lee H, Ahn S Y, Ann J, Ha H, Yoo Y D, Kim Y, Hwang J-Y, Hur K-H, Jang C-G, Pearce LV, Esch TE, Lewin NE, Blumberg PM, Lee J
Eur J Med Chem. 2019 Nov 15; 182:111634.
PMID: 31472474.


In order to discover a novel type of analgesic, we investigated dual activity ligands with TRPV1 antagonism and mu-opioid receptor affinity with the goal of eliciting synergistic analgesia while avoiding the side effects associated with single targeting. Based on a combination approach, a series of 4-benzyl-4-(dimethylamino)piperidinyl analogues were designed, synthesized and evaluated for their receptor activities. Among them, compound 49 exhibited the most promising dual-acting activity toward TRPV1 and the mu-opioid receptor in vitro. In vivo,49 displayed potent, dose-dependent antinociceptive activity in both the 1st and 2nd phases in the formalin assay. Consistent with its postulated mechanism, we confirmed that in vivo, as in vitro, compound 49 both antagonized TRPV1 and functioned as a mu-opioid agonist. This result indicates that dual-acting TRPV1 antagonist/mu-opioid ligands can be made and represent a new and promising class of analgesic.